In terms of TIM-3 expression, specifically, the net negative change stemmed from an initial upregulation in TIM-3 expression when these cells were activated in OpTmizerTM medium, followed by downregulation upon contact of NK cells and cancer targets. The gene discussed is HAVCR2; the disease is cancer.